View in EDS HTML Full Text PDF Full Text

SCALA: a randomized phase I trial comparing subcutaneous and intravenous alemtuzumab in patients with progressive multiple sclerosis.

Saved in:
Bibliographic Details
Title: SCALA: a randomized phase I trial comparing subcutaneous and intravenous alemtuzumab in patients with progressive multiple sclerosis.
Authors: Montalban X; Vall d'Hebron University Hospital and Multiple Sclerosis Centre of Catalonia, Passeig Vall d'Hebron 119-129, Edifici Cemcat, Barcelona 08035, Spain., Rodriguez-Acevedo B; Vall d'Hebron University Hospital and Multiple Sclerosis Centre of Catalonia, Barcelona, Spain., Nos C; Vall d'Hebron University Hospital and Multiple Sclerosis Centre of Catalonia, Barcelona, Spain., Resina M; Vall d'Hebron University Hospital and Multiple Sclerosis Centre of Catalonia, Barcelona, Spain., Forner M; Sanofi, Barcelona, Spain., Wu Y; Sanofi, Beijing, China., Chirieac M; Sanofi, Cambridge, MA, USA.
Source: Therapeutic advances in neurological disorders [Ther Adv Neurol Disord] 2024 Nov 06; Vol. 17, pp. 17562864241291655. Date of Electronic Publication: 2024 Nov 06 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: SAGE Country of Publication: England NLM ID: 101480242 Publication Model: eCollection Cited Medium: Print ISSN: 1756-2856 (Print) Linking ISSN: 17562856 NLM ISO Abbreviation: Ther Adv Neurol Disord Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39513023
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: SCALA: a randomized phase I trial comparing subcutaneous and intravenous alemtuzumab in patients with progressive multiple sclerosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Montalban+X%22">Montalban X</searchLink>; Vall d'Hebron University Hospital and Multiple Sclerosis Centre of Catalonia, Passeig Vall d'Hebron 119-129, Edifici Cemcat, Barcelona 08035, Spain.<br /><searchLink fieldCode="AU" term="%22Rodriguez-Acevedo+B%22">Rodriguez-Acevedo B</searchLink>; Vall d'Hebron University Hospital and Multiple Sclerosis Centre of Catalonia, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Nos+C%22">Nos C</searchLink>; Vall d'Hebron University Hospital and Multiple Sclerosis Centre of Catalonia, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Resina+M%22">Resina M</searchLink>; Vall d'Hebron University Hospital and Multiple Sclerosis Centre of Catalonia, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Forner+M%22">Forner M</searchLink>; Sanofi, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Wu+Y%22">Wu Y</searchLink>; Sanofi, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Chirieac+M%22">Chirieac M</searchLink>; Sanofi, Cambridge, MA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101480242%22">Therapeutic advances in neurological disorders</searchLink> [Ther Adv Neurol Disord] 2024 Nov 06; Vol. 17, pp. 17562864241291655. <i>Date of Electronic Publication: </i>2024 Nov 06 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SAGE%22">SAGE </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101480242 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1756-2856 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217562856%22">17562856 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Neurol Disord <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39513023
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/17562864241291655
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 17562864241291655
    Titles:
      – TitleFull: SCALA: a randomized phase I trial comparing subcutaneous and intravenous alemtuzumab in patients with progressive multiple sclerosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Montalban X
      – PersonEntity:
          Name:
            NameFull: Rodriguez-Acevedo B
      – PersonEntity:
          Name:
            NameFull: Nos C
      – PersonEntity:
          Name:
            NameFull: Resina M
      – PersonEntity:
          Name:
            NameFull: Forner M
      – PersonEntity:
          Name:
            NameFull: Wu Y
      – PersonEntity:
          Name:
            NameFull: Chirieac M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 11
              Text: 2024 Nov 06
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 1756-2856
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Therapeutic advances in neurological disorders
              Type: main
ResultId 1